EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Adoptive cell therapy for cancer treatment

Shi Du, Jingyue Yan, Yonger Xue, Yichen Zhong, Yizhou Dong iD

Exploration · 2023-08 · 3 (4)

DOI: 10.1002/exp.20210058 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Exploration, online erschienen am 02.07.2023. Verfasst von Shi Du und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pharmaceutics and Pharmacology College of Pharmacy Ohio State University Columbus USA. Die Arbeit wurde bisher 104-mal zitiert (Crossref) und nennt 138 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, National Institute of General Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Adoptive cell therapy (ACT) is a rapidly growing anti‐cancer strategy that has shown promise in treating various cancer types. The concept of ACT involves activating patients’ own immune cells ex vivo and then transferring them back to the patients to recognize and eliminate cancer cells. Currently, the commonly used ACT includes tumor‐infiltrating lymphocytes (TILs), genetically engineered immune cells, and dendritic cells (DCs) vaccines. With the advancement of cell culture and genetic engineering techniques, ACT has been used in clinics to treat malignant hematological diseases and many new ACT‐based regimens are in different stages of clinical trials. Here, representative ACT approaches are introduced and the opportunities and challenges for clinical translation of ACT are discussed.

Schlagwörter

Stichwörter der Autor:innen

T‐cell receptorsadoptive cell therapycancer immunotherapychimeric antigen receptorsdendritic cellsmacrophagesnatural killer cellstumor‐infiltrating lymphocytes

Autor:innen und Institutionen

  • Division of Pharmaceutics and Pharmacology College of Pharmacy Ohio State University Columbus USA.
  • Icahn Genomics Institute Precision Immunology Institute Department of Oncological Sciences Tisch Cancer Institute Friedman Brain Institute Icahn School of Medicine at Mount Sinai New York USA.

ORCID-Profile: Yizhou Dong

Förderung

  • NIGMS NIH HHS
  • National Institute of General Medical Sciences

Zitieren

APA

Du, S., Yan, J., Xue, Y., Zhong, Y., & Dong, Y. (2023). Adoptive cell therapy for cancer treatment. Exploration, 3(4). https://doi.org/10.1002/exp.20210058

Vancouver

Du S, Yan J, Xue Y, Zhong Y, Dong Y. Adoptive cell therapy for cancer treatment. Exploration. 2023;3(4). doi:10.1002/exp.20210058

BibTeX
@article{Du2023,
  author = {Du, Shi and Yan, Jingyue and Xue, Yonger and Zhong, Yichen and Dong, Yizhou},
  title = {Adoptive cell therapy for cancer treatment},
  journal = {Exploration},
  year = {2023},
  volume = {3},
  number = {4},
  doi = {10.1002/exp.20210058}
}
Kostenlos starten →